Prestige Biologics (CEO Jae-young Yang), a pharmaceutical company specializing in consigned development and production of biopharmaceuticals (CDMO), aq...
Prestige Biologics, a biopharmaceutical consignment development and pr...
Introducing Prestige Biologics’s
Antibodies are developed using high productivity culture process along with Non-Protein A process and innovative technology
We simultaneously perform conceptual design to detailed design and also consulting to construction to validation with the development team.
Efficient and safe production is possible through full Single-Use System and hybrid manufacturing system.
HD201, a treatment for breast cancer, and HD204, a solid cancer treatment, are major pipelines that have been recognized for their excellent stability and purity.